| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $64K | -99.8% |
| R&D Expense | $37.8M | +29.2% |
| SG&A Expense | $20.3M | +5.8% |
| Operating Income | -$58.1M | -158.7% |
| Pre-tax Income | -$55.3M | -258.9% |
| Income Tax | $197K | -11.7% |
| Net Income | -$55.5M | -255.0% |
| EPS (Basic) | -$1.00 | -257.1% |
| EPS (Diluted) | -$1.00 | -257.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.3M | -51.0% |
| Short-term Investments | $6.0M | -61.2% |
| Accounts Receivable | $13K | -98.4% |
| Current Assets | $50.9M | -47.5% |
| Total Assets | $56.1M | -44.6% |
| Current Liabilities | $13.6M | +60.9% |
| Total Liabilities | $14.1M | +54.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.2M | -116.9% |
| Capital Expenditures | $434K | -42.1% |
| Investing Cash Flow | $9.8M | +384.5% |
| Financing Cash Flow | $1.1M | +381.5% |
| Free Cash Flow | -$51.6M | -112.0% |
| $42.0M |
| -54.5% |